物质使用障碍门诊中丙型肝炎与产科发病率:远程医疗的作用?
本研究为回顾性队列研究,纳入2018年6月至2023年2月物质使用障碍产前门诊的224例患者,评估活动性丙型肝炎对复合产科发病率的影响,以及感染科远程医疗咨询对后续治疗实施的作用。结果显示丙型肝炎患者与非感染者复合产科发病率无差异;远程医疗实施后,就诊率和丙型肝炎治疗率均提高。
要点
- 丙型肝炎患者与非感染者复合产科发病率无差异。
- 远程医疗咨询实施后,患者就诊率由19%升至44%(P=.03)。
- 远程医疗咨询实施后,丙型肝炎治疗率由14%升至57%(P<.01)。
核心结论
- 丙型肝炎患者与非感染者母婴结局相似,但存在多项社会和经济脆弱性指标。
- 感染科远程医疗咨询与随访率和丙型肝炎治疗率提高相关,产科医生能够直接开具处方。
研究设计与样本
- 回顾性队列研究,纳入2018年6月至2023年2月物质使用障碍产前门诊的所有患者,共224例。
- 丙型肝炎远程医疗咨询于2020年3月开始,包括感染科电子病历审查(患者无法就诊时)。
主要发现
- 222例接受筛查的患者中,71例(32%)活动性丙型肝炎阳性。
- 丙型肝炎患者中白人比例高于非感染者(80% vs 58%;P=.02),安非他明使用史(61% vs 32%;P<.01)、注射吸毒史(72% vs 38%;P<.01)、过量用药史(56% vs 29%;P<.01)及美沙酮使用(37% vs 18%;P<.01)比例均更高。
- 复合产科发病率在丙型肝炎患者与非感染者之间无差异。
- 远程医疗前后丙型肝炎诊断率无统计学显著差异(前29例[41%],后42例[27%])。
- 远程医疗后组海洛因使用比例低于远程医疗前组(62% vs 90%;P=.013)。
临床怎么用
- 作者认为,由于物质使用障碍合并丙型肝炎的患者可能面临更多就医障碍,远程医疗可能代表一种干预机会。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Hepatitis C infection often co-occurs with substance use disorders in pregnancy. Accessing hepatitis C treatment is challenging because of loss to follow-up in the postpartum period, attributable to social and financial barriers to care. Telemedicine has been explored as a means of increasing routine postpartum care, but the potential impact on retention in and completion of care for postpartum hepatitis C has not been assessed. OBJECTIVE: This study aimed to evaluate the impact of hepatitis C on obstetrical morbidity in a substance use disorder-specific prenatal clinic, and the effect of Infectious Disease telemedicine consultation on subsequent treatment delivery. STUDY DESIGN: We performed a retrospective cohort study of all patients in our substance use disorder prenatal clinic from June 2018 to February 2023. Telemedicine consults for hepatitis C diagnoses began in March 2020 and included electronic chart review by Infectious Disease when patients were unable to be seen. Our primary outcome was composite obstetrical morbidity (preterm birth, preeclampsia, fetal growth restriction, fetal anomaly, abruption, postpartum hemorrhage, or chorioamnionitis) compared between patients with and without active hepatitis C. We additionally evaluated rates of completed referral and initiation of hepatitis C treatment before and after implementation of telemedicine consult. RESULTS: A total of 224 patients were included. Of the 222 patients who underwent screening, 71 (32%) were positive for active hepatitis C. Compared with patients without hepatitis C, a higher proportion of patients with hepatitis C were White (80% vs 58%; P=.02), had a history of amphetamine use (61% vs 32%; P<.01), injection drug use (72% vs 38%; P<.01), or overdose (56% vs 29%; P<.01), and were on methadone (37% vs 18%; P<.01). There was no difference in the primary outcome of composite obstetrical morbidity. The rate of hepatitis C diagnosis was not statistically significantly different between the pre- and posttelemedicine cohorts (N=29 [41%], N=42 [27%]), and demographics of hepatitis C virus-positive patients were similar, with most being unemployed, single, and publicly insured. A lower proportion of patients in the posttelemedicine group reported heroin use compared with the pretelemedicine cohort (62% vs 90%; P=.013). After implementation of telemedicine, patients were more likely to attend the visit (19% vs 44%; P=.03), and positive patients were much more likely to receive treatment (14% vs 57%; P<.01); 100% of visits in the posttelemedicine group occurred via telemedicine. There were 7 patients who were prescribed treatment by their obstetrician after chart review by Infectious Disease. CONCLUSION: Patients with and without hepatitis C had similar maternal and neonatal outcomes, with multiple indicators of social and financial vulnerability. Telemedicine Infectious Disease consult was associated with increased follow-up and hepatitis C treatment, and obstetricians were able to directly prescribe. Because patients with substance use disorders and hepatitis C may have increased barriers to care, telemedicine may represent an opportunity for intervention.
引用
- Trammel CJ, Beermann S, Goodman B, et al. Hepatitis C and obstetrical morbidity in a substance use disorder clinic: a role for telemedicine? Am J Obstet Gynecol MFM. 2023. PMID: 37951578. doi:10.1016/j.ajogmf.2023.101219
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。